Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other Non-Current Assets (2016 - 2022)

Historic Other Non-Current Assets for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $11.7 million.

  • Avadel Pharmaceuticals' Other Non-Current Assets fell 6923.72% to $11.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $11.7 million, marking a year-over-year decrease of 6923.72%. This contributed to the annual value of $33.8 million for FY2021, which is 3543.85% up from last year.
  • Avadel Pharmaceuticals' Other Non-Current Assets amounted to $11.7 million in Q3 2022, which was down 6923.72% from $11.8 million recorded in Q2 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Other Non-Current Assets peaked at $47.5 million during Q1 2020, and registered a low of $11.7 million during Q3 2022.
  • For the 5-year period, Avadel Pharmaceuticals' Other Non-Current Assets averaged around $30.3 million, with its median value being $33.8 million (2021).
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Other Non-Current Assets soared by 25267.83% in 2018, and later tumbled by 6923.72% in 2022.
  • Avadel Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $36.1 million in 2018, then grew by 8.65% to $39.3 million in 2019, then tumbled by 36.5% to $24.9 million in 2020, then soared by 35.44% to $33.8 million in 2021, then crashed by 65.3% to $11.7 million in 2022.
  • Its last three reported values are $11.7 million in Q3 2022, $11.8 million for Q2 2022, and $39.6 million during Q1 2022.